Literature DB >> 9057663

Molecular analysis of Rh transcripts and polypeptides from individuals expressing the DVI variant phenotype: an RHD gene deletion event does not generate All DVIccEe phenotypes.

N D Avent1, W Liu, J W Jones, M L Scott, D Voak, M Pisacka, J Watt, A Fletcher.   

Abstract

The D antigen is a mosaic comprising at least 30 epitopes. Partial Rh D phenotypes occur when there is absence of one or more of these epitopes, with the remainder expressed. The DVI phenotype is the most common of the partial D phenotypes, lacking most D antigen epitopes (ep D) (epD1, 2, 5-8 using the 9-epitope model or epD 1-4, 7-22, 26-29 using the 30-epitope model). DVI mothers may become immunized by transfusion with D-positive blood (if typed as D-positive using polyclonal typing reagents) or by fetuses which have all of the D antigen. This situation can give rise to severe hemolytic disease of the newborn (HDN). The molecular basis of the DVI phenotype has previously been proposed to occur by two different genetic mechanisms, one (in individuals of DVICcee phenotype) where a gene conversion event generates a hybrid RHD-RHCE-RHD gene; the second (in individuals of DVIccEe phenotype) was proposed to be caused by a partial RHD gene deletion. We present evidence that in four DVICcee phenotypes studied, this phenotype is not generated by a partial RHD gene deletion, but occurs by a similar mechanism to the DVICcee phenotypes. In two individuals we have found hybrid RHD-RHCE-RHD transcripts in both DVICe and DVIcE haplotypes. These differ in that the DVICe transcripts are derived from an RHD gene where exons 4-6 have been replaced with RHCE equivalents (encoding Ala226); the DVIcE transcripts are derived from an RHD gene where exons 4 and 5 are replaced by RHCE equivalents (encoding Pro226). We provide direct evidence that Rh DVI polypeptides are expressed at the erythrocyte surface as full-length polypeptide products. We have used immunoprecipitation experiments using anti-D reactive with DVI erythrocytes followed by immunoblotting the immune complexes with rabbit sera immunoreactive to the fourth external and C-terminal domains of all Rh polypeptides. Our results illustrate that these domains are present on all Rh DVI proteins studied, and suggest that Rh DVI polypeptide species studied here exist as full-length Rh proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9057663

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Red cell genotyping precision medicine: a conference summary.

Authors:  Gregory A Denomme; Waseem Q Anani; Neil D Avent; Gregor Bein; Lynne B Briggs; Razvan C Lapadat; Celina Montemayor; Maria Rios; Maryse St-Louis; Lynne Uhl; Silvano Wendel; Willy A Flegel
Journal:  Ther Adv Hematol       Date:  2017-09-13

2.  The Bloodgen Project of the European Union, 2003-2009.

Authors:  Neil D Avent; Antonio Martinez; Willy A Flegel; Martin L Olsson; Marion L Scott; Núria Nogués; Martin Písăcka; Geoff L Daniels; Eduardo Muñiz-Diaz; Tracey E Madgett; Jill R Storry; Sigrid Beiboer; Petra M Maaskant-van Wijk; Inge von Zabern; Elisa Jiménez; Diego Tejedor; Monica López; Emma Camacho; Goedele Cheroutre; Anita Hacker; Pavel Jinoch; Irena Svobodova; Ellen van der Schoot; Masja de Haas
Journal:  Transfus Med Hemother       Date:  2009-05-28       Impact factor: 3.747

3.  Interlocus gene conversion explains at least 2.7% of single nucleotide variants in human segmental duplications.

Authors:  Beth L Dumont
Journal:  BMC Genomics       Date:  2015-06-16       Impact factor: 3.969

4.  Signals of historical interlocus gene conversion in human segmental duplications.

Authors:  Beth L Dumont; Evan E Eichler
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

5.  Testing for Partial RhD with a D-Screen Diagast Kit in Moroccan Blood Donors with Weak D Expression.

Authors:  Z Kabiri; M Benajiba; K Hajjout; N Dakka; H Bellaoui
Journal:  J Blood Transfus       Date:  2014-10-28

6.  Effects of RHD gene polymorphisms on distinguishing weak D or DEL from RhD- in blood donation in a Chinese population.

Authors:  Jie Shi; Ying Luo
Journal:  Mol Genet Genomic Med       Date:  2019-04-05       Impact factor: 2.183

7.  Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes.

Authors:  Kshitij Srivastava; David Alan Stiles; Franz Friedrich Wagner; Willy Albert Flegel
Journal:  J Hum Genet       Date:  2017-11-16       Impact factor: 3.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.